Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 4
1992 16
1993 8
1994 6
1995 9
1996 6
1997 7
1998 13
1999 7
2000 8
2001 16
2002 9
2003 13
2004 11
2005 23
2006 14
2007 17
2008 17
2009 8
2010 9
2011 17
2012 14
2013 18
2014 21
2015 17
2016 19
2017 13
2018 25
2019 15
2020 6
2021 7
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Results by year

Filters applied: . Clear all
Page 1
Acute and chronic arsenic toxicity.
Ratnaike RN. Ratnaike RN. Postgrad Med J. 2003 Jul;79(933):391-6. doi: 10.1136/pmj.79.933.391. Postgrad Med J. 2003. PMID: 12897217 Free PMC article. Review.
Trimethoprim-sulfamethoxazole.
Cockerill FR, Edson RS. Cockerill FR, et al. Mayo Clin Proc. 1991 Dec;66(12):1260-9. doi: 10.1016/s0025-6196(12)62478-1. Mayo Clin Proc. 1991. PMID: 1749295 Review.
Male Urogenital Disorders and Metabolic Syndrome: Possible Links, Characteristics and Potential Treatment Strategies.
Oztekin CV, Kaya-Sezginer E, Yilmaz-Oral D, Gur S. Oztekin CV, et al. Curr Pharm Des. 2018;24(9):1019-1033. doi: 10.2174/1381612824666171213102836. Curr Pharm Des. 2018. PMID: 29237379 Review.
Although the epidemiological and limited amount of basic science and clinical evidence link MetS to several male urogenital disorders, a holistic approach aiming to define common mechanistic pathways and new possible therapeutic targets are lacking. OBJECTIVE: The current …
Although the epidemiological and limited amount of basic science and clinical evidence link MetS to several male urogenital disorders …
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H. Michalski JM, et al. JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039. Epub 2018 Jun 14. JAMA Oncol. 2018. PMID: 29543933 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The NRG Oncology/RTOG 0126 randomized clinical trial randomized 1532 patients from 104 North American Radiation Therapy Oncology Group institutions March 2002 through August 2008. ...High doses caused more late toxic …
DESIGN, SETTING, AND PARTICIPANTS: The NRG Oncology/RTOG 0126 randomized clinical trial randomized 1532 patients …
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshire KL, Woo HH, Davis ID, Lim TS, Pearse M. Kneebone A, et al. Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3. Lancet Oncol. 2020. PMID: 33002437 Clinical Trial.
We aimed to compare biochemical progression between patients given adjuvant radiotherapy and those given salvage radiotherapy. METHODS: We did a phase 3, randomised, controlled, non-inferiority trial across 32 oncology centres in Australia and New Zealand. ...FINDIN …
We aimed to compare biochemical progression between patients given adjuvant radiotherapy and those given salvage radiotherapy. METHODS: We d …
Artificial sphincter.
Amend B, Toomey P, Sievert KD. Amend B, et al. Curr Opin Urol. 2013 Nov;23(6):520-7. doi: 10.1097/01.MOU.0000434591.02823.d0. Curr Opin Urol. 2013. PMID: 24080811 Review.
Although the AUS seems to be effective in the treatment of neurogenic and non-neurogenic SUI, large randomized, controlled trials are missing. Urethral erosion, atrophy and infection are the primary reported risk factors for high revision rates with most surgeons performin …
Although the AUS seems to be effective in the treatment of neurogenic and non-neurogenic SUI, large randomized, controlled trials are …
Antimicrobials in urogenital infections.
Wagenlehner FM, Wullt B, Perletti G. Wagenlehner FM, et al. Int J Antimicrob Agents. 2011 Dec;38 Suppl:3-10. doi: 10.1016/j.ijantimicag.2011.09.004. Epub 2011 Oct 20. Int J Antimicrob Agents. 2011. PMID: 22019184 Review.
A prudent antibiotic policy therefore has a large impact on society. The clinical classification in uncomplicated cystitis, uncomplicated pyelonephritis, complicated UTI and genital infections is useful, also for the right choice of antibiotic treatment. ...
A prudent antibiotic policy therefore has a large impact on society. The clinical classification in uncomplicated cystitis, uncomplic …
Urogenital/pelvic pain in men.
Baranowski AP. Baranowski AP. Curr Opin Support Palliat Care. 2012 Jun;6(2):213-9. doi: 10.1097/SPC.0b013e3283523f19. Curr Opin Support Palliat Care. 2012. PMID: 22436320 Review.
362 results